Tidepath

Melanocortin peptides

Melanotan II

Also called MT-2

A tanning peptide that isn't FDA-approved, with case reports of moles changing quickly or in worrying ways.

Status
Not approved by the FDA.
Routes we have on file
By injection
Where doses come from
No checked dose range
Half-life
No measured half-life in people for injection under the skin in our sources

What it is

Melanotan II is a lab-made peptide that switches on melanocortin receptors, the same family PT-141 acts on. In skin, these receptors affect color. It isn't FDA-approved.

What makes it distinct

"Melanotan" on its own doesn't say which drug. Melanotan I (afamelanotide) is a different molecule, with an approved product. The two can't be swapped, so Tidepath asks which you mean.

Open questions

  • How long it lasts in the body (pharmacokinetics). No half-life (the time it takes for half a dose to clear) in people for injection under the skin was found. Tidepath doesn't chart its levels.
  • What's actually in the vial, and how pure it is. Tidepath can't check what's in a vial.

Worth knowing

The FDA flags a possible risk of immune reactions (immunogenicity) when compounded Melanotan II (mixed from its ingredients by a pharmacist or doctor) is given by some routes, because the peptide may clump together (aggregation) or carry impurities related to the peptide. Reported side effects include nausea, and a case report describes a racing heart and raised blood pressure after a large dose. Other case reports describe moles and other dark spots on the skin (pigmented lesions) changing quickly or in worrying ways. The FDA also notes published case reports of serious problems, including melanoma, a skin cancer. A 2017 review of case reports says conclusive evidence linking melanotan use to melanoma is lacking. The case reports are why this note exists. Tidepath records what you tell it you're taking, and it can't examine your skin.

More in Melanocortin peptides